Becton Dickinson and Company (BDX)vsPrecision Optics Corporation, Inc. Common stock (POCI)
BDX
Becton Dickinson and Company
$158.27
+1.51%
HEALTHCARE · Cap: $56.49B
POCI
Precision Optics Corporation, Inc. Common stock
$4.49
+4.91%
HEALTHCARE · Cap: $33.81M
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 89694% more annual revenue ($21.92B vs $24.42M). BDX leads profitability with a 8.0% profit margin vs -28.3%. BDX earns a higher WallStSmart Score of 61/100 (C+).
BDX
Buy61
out of 100
Grade: C+
POCI
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+36.9%
Fair Value
$286.42
Current Price
$158.27
$128.15 discount
Intrinsic value data unavailable for POCI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Revenue surging 62.8% year-over-year
Areas to Watch
Moderate valuation
1.6% revenue growth
ROE of 7.0% — below average capital efficiency
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -73.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Market Cap, Price/Book, EPS Growth. PEG of 1.16 suggests the stock is reasonably priced for its growth.
Bull Case : POCI
The strongest argument for POCI centers on Revenue Growth. Revenue growth of 62.8% demonstrates continued momentum.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Revenue Growth, Return on Equity.
Bear Case : POCI
The primary concerns for POCI are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BDX profiles as a value stock while POCI is a hypergrowth play — different risk/reward profiles.
POCI carries more volatility with a beta of 0.35 — expect wider price swings.
POCI is growing revenue faster at 62.8% — sustainability is the question.
BDX generates stronger free cash flow (549M), providing more financial flexibility.
Bottom Line
BDX scores higher overall (61/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Precision Optics Corporation, Inc. Common stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and lighting systems and related components primarily in the United States and the European Economic Area. The company is headquartered in Gardner, Massachusetts.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?